Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine in pre-treated metastatic breast cancer
NCT00003540Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 1998
- Primary completion
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in breast cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 1998; status: completed.
02
Drugs
gemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003540.